This bill ensures that Utah’s medicinal psilocybin and MDMA pilot program can move forward by allowing qualified healthcare providers to participate after the initial healthcare systems declined to do so.
Following months of study, the Utah Mental Illness and Psychotherapy Task Force found that MDMA and psilocybin (“magic mushrooms”) can offer significant benefits to those with mental illness.
Drug policy, like all policy, should be based on facts. In this case, the facts show that psychotherapeutics are safer and less harmful than alcohol and not deserving of their Schedule I classification.
